Prof Harshal Nandurkar
Clinical (Professor)
Department of Medicine
87 Scholarly works
18 Projects
HIGHLIGHTS
2025
Journal article
Global coagulation assays for patients with diabetes and their utility in the prediction of atherothrombotic events
DOI: 10.1016/j.bvth.2025.1000792025
Journal article
Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes
DOI: 10.1007/s11239-025-03077-32025
Journal article
Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia
DOI: 10.1186/s12974-025-03394-72024
Journal article
Development of endothelial-targeted CD39 as a therapy for ischemic stroke
DOI: 10.1016/j.jtha.2024.04.0232023
Journal article
Current challenges in the prevention and management of post-thrombotic syndrome—towards improved prevention
DOI: 10.1007/s12185-023-03651-62023
Journal article
DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays
DOI: 10.1111/ijlh.140202023
Journal article
Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk
DOI: 10.1016/j.thromres.2023.04.016
RECENT SCHOLARLY WORKS
2023
Journal article
N-Terminomic Changes in Neurons During Excitotoxicity Reveal Proteolytic Events Associated With Synaptic Dysfunctions and Potential Targets for Neuroprotection
DOI: 10.1016/j.mcpro.2023.1005432023
Journal article
Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients
DOI: 10.1007/s11239-022-02686-62022
Journal article
Overall Hemostatic Potential Assay Detects Risk of Progression to Post-Thrombotic Syndrome in Anticoagulated Patients following Deep Vein Thrombosis
DOI: 10.3390/diagnostics12123165
RECENT PROJECTS
2014
Research Grant
A Multi-Centre Double-Blind Randomised Placebo-Controlled Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension
2014
Research Grant
Targeting GRP-78 as a Means to Overcome Drug Resistance and as a Therapeutic Modaliaty Against Multiple Myeloma
2013
Research Grant
Targeting GRP-78 as a Means to Overcome Drug Resistance and as a Therapeutic Modaliaty Against Multiple Myeloma
2013
Internal Research Grant
Characterization of a Novel Regulator of Haemostasis
2011
Research Grant
Study of New Mechanisms That Control Blood Clotting